Macquarie Group LTD Fulgent Genetics, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $12,551 - $21,097	-331 Reduced 39.93%	498 $32,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $33,266 - $50,024	498 Added 150.45%	829 $76,000
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $1,838 - $5,699	31 Added 10.33%	331 $32,000
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $9,303 - $15,630	300 New	300 $16,000
Q2 2020 Aug 11, 2020	SELL	$8.89 - $18.28 $31,790 - $65,369	-3,576 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.75 - $19.75 $24,138 - $70,626	3,576 New	3,576 $38,000

207

17.1M

2.36M

47.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $498M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.